Performance analysis of Clearside Biomedical, Inc. Common Stock (CLSD)
Annual Return
Over the past 3 years, CLSD has had an average annual return of -71.20%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, CLSD has had an average annual return of -60.63%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, CLSD has had an average annual return of -42.58%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Jun 2, 2016, CLSD has had an average annual return of -42.70%, underperforming the benchmark SPY, which returned +15.45% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -97.10% | -18.84% | +4.47% | -59.27% | +0.37% | -5.53% | +171% | -84.71% | -21.70% | +23.31% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | |||||||
| 2025 | -2.06% | -7.56% | +6.75% | -5.77% | -11.99% | +5.05% | -47.87% | -11.83% | -28.01% | +2.47% | -89.84% | -97.10% | |
| 2024 | +6.82% | +12.01% | +9.27% | -17.63% | +11.10% | -7.15% | -12.33% | -11.39% | +25.77% | -19.69% | +2.91% | -9.53% | -18.84% |
| 2023 | +25.89% | -12.08% | -16.14% | -2.86% | +6.96% | +3.69% | +4.47% | -22.24% | -4.38% | -16.75% | +39.44% | +15.87% | +4.47% |
| 2022 | -29.08% | -18.22% | +43.59% | -33.21% | -15.02% | +13.11% | +4.73% | -11.02% | -17.51% | +0.83% | +6.17% | -7.43% | -59.27% |
| 2021 | +14.24% | +5.77% | -25.38% | +24.27% | -16.44% | +89.85% | +1.03% | +40.04% | -12.91% | -9.00% | -32.78% | -25.07% | +0.37% |
| 2020 | +30% | -40.58% | -24.11% | +16.46% | -6.04% | +1.05% | -12.77% | +4.86% | -10.46% | -12.34% | +48.87% | +36.33% | -5.52% |
| 2019 | +10.30% | +22.85% | -4.85% | -10.14% | -12.11% | -10.78% | +16.26% | -46.50% | +4.20% | +100% | +14.27% | +101.41% | +171% |
| 2018 | -7.14% | -0.62% | +66.11% | +13.51% | -19.05% | +8.42% | -16.65% | -23.57% | -9.69% | -11.87% | -72.87% | -27.22% | -84.71% |
| 2017 | -16.67% | +5.37% | +1.15% | +0.25% | -13.56% | +32.41% | -5.38% | -18.92% | +25.04% | -18.53% | +0% | -1.69% | -21.70% |
Drawdown analysis of Clearside Biomedical, Inc. Common Stock (CLSD)
The maximum drawdown for the CLSD was -99.89%, occurring on Nov 28, 2025. This drawdown has not yet recovered.
The current CLSD drawdown is -99.89%.
Since Jun 2, 2016 CLSD has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.89% | Oct 11, 2016 | 2296 | Nov 28, 2025 | Ongoing | Ongoing | Ongoing |
| -17.17% | Jun 2, 2016 | 46 | Aug 8, 2016 | 11 | Aug 23, 2016 | 57 |
| -5.93% | Sep 28, 2016 | 1 | Sep 29, 2016 | 2 | Oct 3, 2016 | 3 |
| -5.91% | Aug 23, 2016 | 3 | Aug 26, 2016 | 2 | Aug 30, 2016 | 5 |
| -5.71% | Sep 9, 2016 | 1 | Sep 12, 2016 | 5 | Sep 19, 2016 | 6 |
| -4.10% | Oct 3, 2016 | 1 | Oct 4, 2016 | 1 | Oct 5, 2016 | 2 |
| -1.44% | Sep 7, 2016 | 1 | Sep 8, 2016 | 1 | Sep 9, 2016 | 2 |
| -1.09% | Sep 21, 2016 | 1 | Sep 22, 2016 | 1 | Sep 23, 2016 | 2 |
| -1.08% | Aug 30, 2016 | 1 | Aug 31, 2016 | 1 | Sep 1, 2016 | 2 |
| -0.68% | Sep 2, 2016 | 1 | Sep 6, 2016 | 1 | Sep 7, 2016 | 2 |